• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Delivered as Unsterile Product (1421)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/07/2022
Event Type  malfunction  
Event Description
It was reported 10 bd q-syte luer access split septums was discolored.This occurred 3 times.The additional defect of "discoloration" was observed through the investigation by bd (b)(4) (b)(6) 2022.The following information was provided by the initial reporter: a joint leak occurred in icu.
 
Manufacturer Narrative
Our quality engineer inspected the photograph submitted for evaluation.Bd received one photograph which displayed three stopcock devices connected together along with three q-syte (one q-syte per stopcock) attached to the female luer of the stopcock.A black coloration can be seen at the male luer of each q-syte.It is not possible to determine, based on the photo, if the black coloration is media or an effect of the lighting.The black coloration does not extend past the threads.Additionally, the septum of the q-syte in the middle of the photo has a yellow coloring to it.The photo does not provide evidence of a leak.From review of the photograph, leakage was not confirmed.The photo provided for this incident did not present sufficient evidence to identify or confirm the alleged failure or to establish a definite root cause.Discoloration was observed.A root cause could not be determined.Examination of the actual product involved may provide clarification as to the cause for the reported failure.A device history record review showed no non-conformances associated with this issue during the production of this batch.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.The reported defect of leakage could not be confirmed based on the photo evidence.A root cause cannot be established for the unconfirmed defect.The defect discoloration of the septum has been confirmed.Since the device was used, the root cause cannot be conclusively linked to either assembly or application.
 
Manufacturer Narrative
H.6.Investigation: our quality engineer inspected the photograph submitted for evaluation.Bd received one photograph which displayed three stopcock devices connected together along with three q-syte (one q-syte per stopcock) attached to the female luer of the stopcock.A black coloration can be seen at the male luer of each q-syte.It is not possible to determine, based on the photo, if the black coloration is media or an effect of the lighting.The black coloration does not extend past the threads.Additionally, the septum of the q-syte in the middle of the photo has a yellow coloring to it.The photo does not provide evidence of a leak.From review of the photograph, leakage was not confirmed.The photo provided for this incident did not present sufficient evidence to identify or confirm the alleged failure or to establish a definite root cause.Discoloration was observed.A root cause could not be determined.A device history record review showed no non-conformances associated with this issue during the production of this batch.H3 other text : see h.10.
 
Event Description
It was reported 10 bd q-syte luer access split septums was discolored.This occurred 3 times.The additional defect of "discoloration" was observed through the investigation by bd sandy plant (b)(6)2022.The following information was provided by the initial reporter: a joint leak occurred in icu.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT SEPTUM
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13971833
MDR Text Key288875776
Report Number9610847-2022-00124
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number385100
Device Catalogue Number385100
Device Lot Number1210005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2022
Initial Date FDA Received03/31/2022
Supplement Dates Manufacturer Received04/05/2022
Supplement Dates FDA Received04/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-